CRISPR‐Cas13d effectively targets SARS‐CoV‐2 variants, including Delta and Omicron, and inhibits viral infection

The recent pandemic of variants of concern (VOC) of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) highlights the need for innovative anti‐SARS‐CoV‐2 approaches in addition to vaccines and antiviral therapeutics. Here, we demonstrate that a CRISPR‐Cas13‐based strategy against SARS‐CoV‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zongzhi, Gao, Xiang, Kan, Chuanwen, Li, Lingyu, Zhang, Yuan, Gao, Yibo, Zhang, Shengyuan, Zhou, Liangji, Zhao, Hui, Li, Mingkun, Zhang, Zheng, Sun, Yingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887993/
https://www.ncbi.nlm.nih.gov/pubmed/36744219
http://dx.doi.org/10.1002/mco2.208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887993/
https://www.ncbi.nlm.nih.gov/pubmed/36744219
http://dx.doi.org/10.1002/mco2.208

Ejemplares similares